# TransVascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transvascular

- Industry: Medical Devices & Equipment
- Headquarters: Menlo Park, US
- Total disclosed funding: $12M
- Latest round: Series D (May 20, 2002)
- Investors on record: 6

## About

Established in 1996 and based in Menlo Park, California, TransVascular, Inc. develops medical devices for coronary artery disease, congestive heart failure and peripheral arterial disease.

## Funding rounds

- Series D, May 20, 2002, $11M — New Enterprise Associates, Three Arch Partners, Johnson & Johnson Innovation, Bessemer Venture Partners, Medtronic, Jomed NV
- Series A, Dec 1, 1996, $0.8M — New Enterprise Associates, Three Arch Partners

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series D
- Three Arch Partners (https://capitalatlas.ai/funds/three-arch-partners) — Series A, Series D
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series D
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series D
- Medtronic — Series D
- Jomed NV — Series D